296 related articles for article (PubMed ID: 11091782)
1. A certain fate: spread of HIV among young injecting drug users in Manipur, north-east India.
Eicher AD; Crofts N; Benjamin S; Deutschmann P; Rodger AJ
AIDS Care; 2000 Aug; 12(4):497-504. PubMed ID: 11091782
[TBL] [Abstract][Full Text] [Related]
2. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
3. HIV infection among injecting drug users in north-east Malaysia, 1992.
Singh S; Crofts N
AIDS Care; 1993; 5(3):273-81. PubMed ID: 8218462
[TBL] [Abstract][Full Text] [Related]
4. Injecting and sexual risk behaviours, sexually transmitted infections and HIV prevalence in injecting drug users in three states in India.
Mahanta J; Medhi GK; Paranjape RS; Roy N; Kohli A; Akoijam BS; Dzuvichu B; Das HK; Goswami P; Thongamba G;
AIDS; 2008 Dec; 22 Suppl 5():S59-68. PubMed ID: 19098480
[TBL] [Abstract][Full Text] [Related]
5. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
6. Prevalence rates and risk factors for hepatitis C among drug users not in treatment in Malaysia.
Vicknasingam B; Narayanan S; Navaratnam V
Drug Alcohol Rev; 2009 Jul; 28(4):447-54. PubMed ID: 19594801
[TBL] [Abstract][Full Text] [Related]
7. Rapid spread of HIV among injecting drug users in north-eastern states of India.
Sarkar S; Das N; Panda S; Naik TN; Sarkar K; Singh BC; Ralte JM; Aier SM; Tripathy SP
Bull Narc; 1993; 45(1):91-105. PubMed ID: 8305909
[TBL] [Abstract][Full Text] [Related]
8. Epidemic of HIV coupled with hepatitis C virus among injecting drug users of Himalayan West Bengal, Eastern India, Bordering Nepal, Bhutan, and Bangladesh.
Sarkar K; Bal B; Mukherjee R; Chakraborty S; Niyogi SK; Saha MK; Bhattacharya SK
Subst Use Misuse; 2006; 41(3):341-52. PubMed ID: 16467010
[TBL] [Abstract][Full Text] [Related]
9. HIV infection among injecting drug users in Asia: an evolving public health crisis.
Wodak A; Crofts N; Fisher R
AIDS Care; 1993; 5(3):313-20. PubMed ID: 8218466
[TBL] [Abstract][Full Text] [Related]
10. Relationship of national highway with injecting drug abuse and HIV in rural Manipur, India.
Sarkar K; Panda S; Das N; Sarkar S
Indian J Public Health; 1997; 41(2):49-51. PubMed ID: 9988977
[TBL] [Abstract][Full Text] [Related]
11. HIV, hepatitis B and sexual practices in the street-recruited injecting drug users of Calcutta: risk perception versus observed risks.
Panda S; Chatterjee A; Bhattacharjee S; Ray B; Saha MK; Bhattacharya SK
Int J STD AIDS; 1998 Apr; 9(4):214-8. PubMed ID: 9598748
[TBL] [Abstract][Full Text] [Related]
12. Differentiated risk behaviour for HIV and hepatitis among injecting drug users (IDUs).
Nordén L; Lidman C
Scand J Infect Dis; 2005; 37(6-7):493-6. PubMed ID: 16012010
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C seroprevalence amongst injecting drug users attending a methadone programme.
Chetwynd J; Brunton C; Blank M; Plumridge E; Baldwin D
N Z Med J; 1995 Sep; 108(1007):364-6. PubMed ID: 7566775
[TBL] [Abstract][Full Text] [Related]
14. Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention.
Morissette C; Cox J; De P; Tremblay C; Roy E; Allard R; Stephenson R; Graves L
Int J Drug Policy; 2007 May; 18(3):204-12. PubMed ID: 17689367
[TBL] [Abstract][Full Text] [Related]
15. Background demographics and risk behaviors of injecting drug users in Karachi, Pakistan.
Parviz S; Fatmi Z; Altaf A; McCormick JB; Fischer-Hoch S; Rahbar M; Luby S
Int J Infect Dis; 2006 Sep; 10(5):364-71. PubMed ID: 16793307
[TBL] [Abstract][Full Text] [Related]
16. HIV risk behavior, street outreach, and condom use in eight high-risk populations.
Anderson JE; Cheney R; Clatts M; Faruque S; Kipke M; Long A; Mills S; Toomey K; Wiebel W
AIDS Educ Prev; 1996 Jun; 8(3):191-204. PubMed ID: 8806949
[TBL] [Abstract][Full Text] [Related]
17. High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey.
Johnston L; Saumtally A; Corceal S; Mahadoo I; Oodally F
Int J Drug Policy; 2011 Jul; 22(4):252-8. PubMed ID: 21700442
[TBL] [Abstract][Full Text] [Related]
18. Sexual transmission risk among noninjecting heroin users infected with human immunodeficiency virus or hepatitis C virus.
Neaigus A; Miller M; Friedman SR; Des Jarlais DC
J Infect Dis; 2001 Aug; 184(3):359-63. PubMed ID: 11443564
[TBL] [Abstract][Full Text] [Related]
19. [Prevalence of human immunodeficiency virus and hepatitis C virus, and associated factors among injecting drug users in Catalonia].
Huntington S; Folch C; González V; Meroño M; Ncube F; Casabona J
Enferm Infecc Microbiol Clin; 2010 Apr; 28(4):236-8. PubMed ID: 19695744
[TBL] [Abstract][Full Text] [Related]
20. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
